Navigating the area of end-of-life care and access to medications like Nembutal in New South Wales, NSW, requires a careful grasp of the intricate legal system. Currently, Nembutal does not have a approved place on the Pharmaceutical Benefits Scheme (the scheme) and is therefore not routinely prescribed by clinical professionals. Its application is